A Comparison of Remifentanil Patient-Controlled Analgesia vs. Oral Morphine Analgesia for Dressing Changes in Burns Patients.

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2010
INTERVENTION: Trade Name: Remifentanil Product Name: Remifentanil Pharmaceutical Form: Powder for solution for infusion Trade Name: Oramorph Product Name: Oramorph Pharmaceutical Form: Oral solution CONDITION: Pain experienced by patients with pre‐existing burns presenting to the burns outpatients unit requiring two or more dressing changes PRIMARY OUTCOME: Main Objective: To determine whether remifentanil PCA or oral morphine provides more effective analgesia for out‐patient dressing changes in the burns unit.; Primary end point(s): Maximum visual analogue scale (VAS) pain score during the dressing change procedure.; Secondary Objective: To determine if burns patients prefer traditional analgesia or remifentanil analgesia for dressing changes INCLUSION CRITERIA: • Outpatients requiring two or more dressing changes for burns who would normally be considered appropriate for oral morphine analgesia. • ASA 1 and 2 patients over the age of 18 years Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Epistemonikos ID: 6aa15134e1691692a179e83ee4f46dd4f0540dea
First added on: Aug 22, 2024